Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (3159)	12/5/1997 11:50:00 PM
From: PAL	Read Replies (1) \| Respond to of 6136

Dr Izzy: I think that AGPH is attractive takeover candidate at current prices. Dr. Johnson has a fiduciary obligation to optimize shareholders' value, hence his appearance on Monday's Squawk Box with Mark Haines. I believe that there is a fee to appear on that program, but there is no advanced and agreed questions to be addressed to the guest. Many scientists are happier to do work in their area, and possibly Dr Jonhson will be more suited in biotech research, although I have to tip my hat off for his quick reaction against the rapid devaluation of AGPH stock recently.